Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats

Journal of Bone and Mineral Metabolism

Volumn 20, Issue 1, 2002, Pages 14-20

  Mochizuki, Shin Ichi ^a   Fujise, Nobuaki ^a   Higashio, Kanji ^a   Tsuda, Eisuke ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

Bone mineral density; Bone strength; Immobilization; Osteoclastogenesis inhibitory factor; Osteoprotegerin

Indexed keywords

OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE STRENGTH; CONTROLLED STUDY; FEMUR NECK; IMMOBILIZATION; MALE; NEURECTOMY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; RAT; TRABECULAR BONE;

ANIMALS; BODY WEIGHT; BONE DENSITY; BONE RESORPTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR; GLYCOPROTEINS; INJECTIONS, INTRAMUSCULAR; MALE; OSTEOPROTEGERIN; RATS; RATS, INBRED F344; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RESTRAINT, PHYSICAL; SCIATIC NERVE;

EID: 0036152025     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s774-002-8441-x     Document Type: Article

References (23)

1. Advances in bone biology: The osteoclast
2. Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation
3. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
4. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
5. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
6. Osteoclast differentiation factor is a ligand for ostcoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
7. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
8. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclasts
9. 2, or parathyroid hormone in the microenvironment of bone
10. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts
11. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
12. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
13. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
14. Effect of (asul,7)-eel calcitonin on the prevention of osteoporosis induced by combination of immobilization and ovariectomy in the rat
15. Parathyroid and thyroid hormones in the development of immobilization osteoporosis
16. Indomethacin inhibition of tenotomy-induced bone resorption in rats
17. Skeletal unloading induces resistance to insulin-like growth factor I
18. Osteoprotegerin mitigates tail suspensioninduced osteopenia
19. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor
20. Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation
21. Immobilization hypercalcemia
22. Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells
23. Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts